Dipeptidyl Peptidase-4 Inhibitors

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study

NIH-funded research shows a modest reduction in obesity-related cancer risk and all-cause mortality among diabetic adults using GLP-1 receptor agonists, with notable benefits for women.